The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats

Neuroscience Letters

Volumn 346, Issue 3, 2003, Pages 137-140

  Scruggs, Jennifer L ^a   Schmidt, Dennis ^a   Deutch, Ariel Y ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

5 HT2A receptor; Cortex; Glutamate; Hallucinogen; In vivo microdialysis; Thalamus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; GLUTAMATE RECEPTOR; GLYCINE; SEROTONIN 2A ANTAGONIST;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HALLUCINATION; INTERCELLULAR SPACE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SOMATOSENSORY CORTEX;

EID: 0037630660     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00547-0     Document Type: Article

References (17)

1. Abi-Saab W.M., Bubser M., Roth R.H., Deutch A.Y. 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology. 20:1999;92-96.
2. Aghajanian G.K., Marek G.J. Serotonin and hallucinogens. Neuropsychopharmacology. 21:1999;16S-23S.
3. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
4. Aghajanian G.K., Marek G.J. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825:1999;161-171.
5. Berry S.A., Shah M.C., Khan N., Roth B.L. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol. Pharmacol. 50:1996;306-313.
6. Cornea-Hebert V., Riad M., Wu C., Singh S.K., Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J. Comp. Neurol. 409:1999;187-209.
7. Gritti I., Mainville L., Mancia M., Jones B.E. GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat. J. Comp. Neurol. 383:1997;163-177.
8. Kharazia V.N., Weinberg R.J. Glutamate in thalamic fibers terminating in layer IV of primary sensory cortex. J. Neurosci. 14:1994;6021-6032.
9. Newton R.A., Phipps S.L., Flanigan T.P., Newberry N.R., Carey J.E., Kumar C., McDonald B., Chen C., Elliott J.M. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs. J. Neurochem. 67:1996;2521-2531.
10. Scruggs J.L., Patel S., Bubser M., Deutch A.Y. DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20:2000;8846-8852.
11. Shergill S.S., Cameron L.A., Brammer M.J., Williams S.C., Murray R.M., McGuire P.K. Modality specific neural correlates of auditory and somatic hallucinations. J. Neurol. Neurosurg. Psychiatry. 71:2001;688-690.
12. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., Seaward J., McKenna P., Chua S.E., Schnorr L., Jones T., Frackowiak R.S.J. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
13. Smith R.L., Barrett R.J., Sanders-Bush E. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology. 144:1999;248-254.
14. Vollenweider F.X., Leenders K.L., Scharfetter C., Maguire P., Stadelmann O., Angst J. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology. 16:1997;357-372.
15. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Babler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport. 9:1998;3897-3902.
16. Willins D.L., Deutch A.Y., Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27:1997;79-82.
17. Zhai M.S., George C.A., Zhai J., Nisenbaum E.S., Johnson M.P., Nisenbaum L.K. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Neuropsychopharmacology. 28:2002;45-52.